Planned OU trials test opaganib after CAR T-cell therapy for high-risk myeloma
A National Cancer Institute grant will fund planned OU trials testing whether opaganib can enhance CAR T-cell activity against ultra-high-risk ...
Tag: SK2
POPULAR NEWS
-
Planned OU trials test opaganib after CAR T-cell therapy for high-risk myeloma
-
Research report: Timeliness of outbreak detection and response: an operational evaluation of the 7-1-7 framework in district Mardan, Khyber Pakhtunkhwa, Pakistan
-
Research report: Physiological and biophysical evidence associates FeRbohB with rutin-mediated responses to PEG-simulated water deficit during common buckwheat germination
-
Review quantifies birds’ role as nutrient transporters